Device evaluation: a correlation between the device and the reported event could not be conclusively determined through this evaluation.The report of outflow graft thrombus could not be confirmed through this evaluation.The evaluation of the device did not reveal any device-related issues.The pump was returned assembled with the driveline cut approximately 2.5¿ from the pump housing and the distal portion was not returned.The sealed inflow conduit was returned detached from the pump housing.The sealed outflow graft conduit was returned attached to its respective pump port.The outflow bend relief and collar were detached from the remaining outflow hardware.Upon disassembly, visual inspection of the pump blood-contacting surfaces, including the returned portion of the outflow graft, revealed no evidence of adhered depositions or thrombus formations.Examination of the pump bearings, rotor, and blood-contacting surfaces under a microscope did not reveal any anomalies related to wear or damage.Electrical continuity testing of the returned portion of the driveline did not reveal any discontinuities or shorts.Functional testing of the pump under normal operating conditions revealed normal pump power consumption and pressure values comparable to the data recorded during the manufacturing process.The pump operated as intended.The implant kit was shipped with the heartmate ii lvas ifu.Section 1 lists device thrombosis as an adverse event that may be associated with the use of the hmii lvas.Section 6 explains indications of thrombus and potentially affected pump parameters, as well as how to respond to such an event.Section 6 outlines recommended anticoagulation therapy and inr range.A review of the device history records revealed the device met applicable specifications.No further information was provided.The manufacturer is closing the file on this event.
|